DaVita HealthCare Valuation
| DVA Stock | USD 164.14 2.74 1.70% |
At this time, the firm appears to be fairly valued. DaVita HealthCare shows a prevailing Real Value of $158.32 per share. The current price of the firm is $164.14. Our model computes the value of DaVita HealthCare from inspecting the firm fundamentals such as Current Valuation of 24.35 B, profit margin of 0.07 %, and Return On Asset of 0.0694 as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting DaVita HealthCare's valuation include:
Price Book 34.2337 | Enterprise Value 24.3 B | Enterprise Value Ebitda 9.4409 | Price Sales 1.0629 | Forward PE 14.1044 |
Fairly Valued
Today
Please note that DaVita HealthCare's price fluctuation is very steady at this time. Calculation of the real value of DaVita HealthCare is based on 3 months time horizon. Increasing DaVita HealthCare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since DaVita HealthCare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of DaVita Stock. However, DaVita HealthCare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 164.14 | Real 158.32 | Target 113.0 | Hype 164.14 | Naive 171.03 |
The real value of DaVita Stock, also known as its intrinsic value, is the underlying worth of DaVita HealthCare Company, which is reflected in its stock price. It is based on DaVita HealthCare's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of DaVita HealthCare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of DaVita HealthCare Partners helps investors to forecast how DaVita stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of DaVita HealthCare more accurately as focusing exclusively on DaVita HealthCare's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use DaVita HealthCare's intrinsic value based on its ongoing forecasts of DaVita HealthCare's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against DaVita HealthCare's closest peers. If more than one evaluation category is relevant for DaVita HealthCare we suggest using both methods to arrive at a better estimate.
DaVita HealthCare Cash |
|
DaVita Valuation Trend
Comparing DaVita HealthCare's enterprise value against its market capitalization is a good way to estimate the value of DaVita HealthCare Partners uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
DaVita HealthCare Total Value Analysis
DaVita HealthCare Partners is currently anticipated to have company total value of 24.35 B with market capitalization of 13.46 B, debt of 11.12 B, and cash on hands of 244.09 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the DaVita HealthCare fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
24.35 B | 13.46 B | 11.12 B | 244.09 M |
DaVita HealthCare Investor Information
About 49.0% of the company shares are held by company insiders. The company has Price/Earnings To Growth (PEG) ratio of 1.22. DaVita HealthCare recorded earning per share (EPS) of 9.27. The entity had not issued any dividends in recent years. The firm had 2:1 split on the 9th of September 2013. Based on the measurements of operating efficiency obtained from DaVita HealthCare's historical financial statements, DaVita HealthCare Partners may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.17 | 0.132 |
|
| |||||
| Total Cash From Operating Activities | 2.2 B | 2.1 B |
|
| |||||
| Operating Income | 998.7 M | 1.6 B |
|
|
DaVita HealthCare Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. DaVita HealthCare has an asset utilization ratio of 68.9 percent. This suggests that the Company is making $0.69 for each dollar of assets. An increasing asset utilization means that DaVita HealthCare Partners is more efficient with each dollar of assets it utilizes for everyday operations.DaVita HealthCare Ownership Allocation
DaVita HealthCare holds a total of 82.02 Million outstanding shares. Over half of DaVita HealthCare's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that obtain positions in a given instrument to benefit from reduced trade commissions. Please note that on January 17, 2024, Senator Jerry Moran of US Senate acquired under $15k worth of DaVita HealthCare's common stock.DaVita HealthCare Profitability Analysis
The company reported the last year's revenue of 12.14 B. Total Income to common stockholders was 691.53 M with profit before taxes, overhead, and interest of 3.4 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates DaVita HealthCare's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in DaVita HealthCare and how it compares across the competition.
About DaVita HealthCare Valuation
The stock valuation mechanism determines DaVita HealthCare's current worth on a weekly basis. Our valuation model uses a comparative analysis of DaVita HealthCare. We calculate exposure to DaVita HealthCare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of DaVita HealthCare's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 3.8 B | 2.1 B | |
| Pretax Profit Margin | 0.10 | 0.08 | |
| Operating Profit Margin | 0.13 | 0.17 | |
| Net Profit Margin | 0.06 | 0.05 | |
| Gross Profit Margin | 0.31 | 0.34 |
DaVita HealthCare Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 93.2 M | |
| Quarterly Earnings Growth Y O Y | -0.046 | |
| Forward Price Earnings | 14.1044 |
DaVita HealthCare Current Valuation Indicators
Valuation refers to the process of determining the present value of DaVita HealthCare Partners and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value DaVita we look at many different elements of the entity such as DaVita's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as DaVita HealthCare, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use DaVita HealthCare's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes DaVita HealthCare's worth.Complementary Tools for DaVita Stock analysis
When running DaVita HealthCare's price analysis, check to measure DaVita HealthCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DaVita HealthCare is operating at the current time. Most of DaVita HealthCare's value examination focuses on studying past and present price action to predict the probability of DaVita HealthCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DaVita HealthCare's price. Additionally, you may evaluate how the addition of DaVita HealthCare to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |